期刊文献+

盐酸伊立替康及注射液的HPLC测定 被引量:12

Determination of Irinotecan Hydrochloride and Its Injection by HPLC
下载PDF
导出
摘要 采用 RP- HPL C法测定盐酸伊立替康及注射液的含量和有关物质。用十八烷基键合硅胶为固定相 ,0 .0 5 m ol/L磷酸盐缓冲液 (p H4.0 ) -甲醇 -乙腈 (4 5∶ 5 5∶ 5 )为流动相 ,检测波长 2 5 4nm,最低检出量为 0 .2 ng,线性范围 10~10 0 mg/ L (r=0 .9998) ,精密度 (RSD)为 0 .0 12 % ,平均回收率为 99.0 % ,RSD=0 .0 13% A RP HPLC method was developed to determine irinotecan hydrochloride and its injection. A C 18 column was used, with the mobile phase of 0.05 mol/L phosphate buffer (pH4.0) methanol acetonitrile(45∶55∶5). The detection wavelength was 254 nm, the detective limit was 0.2 ng. The calibration curve was linear in the range of 10~100 mg/L with r =0.9998. The RSD was 0.012% and the average recovery was 99.0%( RSD =0.013%).
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2001年第6期268-269,共2页 Chinese Journal of Pharmaceuticals
关键词 盐酸伊立替康 有关物质 RP-HPLC 测定 注射液 抗癌药 irinotecan hydrochloride related substance HPLC determination
  • 相关文献

参考文献3

  • 1[1]Anonymous. Irinotecan. [J/CD] Pharma Projects, 1996, (5): a1404-a1405. 被引量:1
  • 2[2]Wiseman LR, Markham A. Irinotecan--A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer [J]. Drugs, 1996, 52(4)∶606-623. 被引量:1
  • 3[3]Anonymous. Irinotecan--Antineoplastic [J]. Drugs Future, 1996, 21(3)∶316-317. 被引量:1

同被引文献62

引证文献12

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部